A federal judge is likely to rule soon in Texas A Case That Could Block Delivery of a Key Abortion Drug — a decision that will have wide-ranging implications for abortion access across the country, including in Democratic-led states where abortion rights are protected.
Lawsuit filed by several opponentsabortion Groups and doctors aim against the US Food and Drug Administration to revoke decades-old government approval of mifepristone, one of two drugs used in medication abortions.
Abortion rights advocates say that if the judge in the case, Matthew Kaczmarik of the Northern District of Texas, favoring anti-abortion groups. Such a ruling could trigger the most far-reaching limits on abortion access since the Supreme Court overturned Roe v. Wade In June.
Here’s a look at medication abortion and how the case could shape abortion care across the country: